Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monia Guidi

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Antimicrobial Chemotherapy|April 1, 2016
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individualsCatalina Barceló, Frédéric Gaspar, Manel Aouri, et al.
British Journal of Clinical Pharmacology|January 25, 2026
Population pharmacokinetic modelling of amoxicillin in human breast milk-A contribution from the ConcePTION projectSarah Baklouti, Virginie Rigourd, Alice Panchaud, et al.
Clinical Pharmacokinetics|November 20, 2025
Population Pharmacokinetics of Propofol in Critically Ill Patients with and Without Extracorporeal Membrane OxygenationStéphane Bertin, David Haefliger, Thomas Mercier, et al.
Therapeutic Drug Monitoring|September 24, 2025
Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current ChallengesSandro Carrara, Nicolas Widmer, Francesca Rodino, et al.
Cancer Chemotherapy and Pharmacology|June 12, 2026
Model-based meta-analysis of individual patient data for the characterization of intravenous 5-fluorouracil population pharmacokineticsMyriam Briki, Paul Thoueille, Markus Joerger, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2023
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administrationPaul Thoueille, Susana Alves Saldanha, Vincent Desfontaine, et al.
AIDS (London, England)|September 7, 2019
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIVPerrine Courlet, Felix Stader, Monia Guidi, et al.
Clinical Pharmacokinetics|September 26, 2019
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic AnalysesAnaïs Glatard, Monia Guidi, Aurélie Delacrétaz, et al.
Clinical Pharmacokinetics|April 14, 2020
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIVPerrine Courlet, Laurent A Decosterd, Susana Alves Saldanha, et al.
Frontiers in Pediatrics|August 14, 2025
Pharmacokinetics of levosimendan in critically Ill children on extracorporeal membrane oxygenation: a prospective observational studyStéphane Bertin, David Haefliger, Maria-Helena Perez, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|April 1, 2016
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individualsCatalina Barceló, Frédéric Gaspar, Manel Aouri, et al.
British Journal of Clinical Pharmacology|January 25, 2026
Population pharmacokinetic modelling of amoxicillin in human breast milk-A contribution from the ConcePTION projectSarah Baklouti, Virginie Rigourd, Alice Panchaud, et al.
Clinical Pharmacokinetics|November 20, 2025
Population Pharmacokinetics of Propofol in Critically Ill Patients with and Without Extracorporeal Membrane OxygenationStéphane Bertin, David Haefliger, Thomas Mercier, et al.
Therapeutic Drug Monitoring|September 24, 2025
Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current ChallengesSandro Carrara, Nicolas Widmer, Francesca Rodino, et al.
Cancer Chemotherapy and Pharmacology|June 12, 2026
Model-based meta-analysis of individual patient data for the characterization of intravenous 5-fluorouracil population pharmacokineticsMyriam Briki, Paul Thoueille, Markus Joerger, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2023
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administrationPaul Thoueille, Susana Alves Saldanha, Vincent Desfontaine, et al.
AIDS (London, England)|September 7, 2019
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIVPerrine Courlet, Felix Stader, Monia Guidi, et al.
Clinical Pharmacokinetics|September 26, 2019
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic AnalysesAnaïs Glatard, Monia Guidi, Aurélie Delacrétaz, et al.
Clinical Pharmacokinetics|April 14, 2020
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIVPerrine Courlet, Laurent A Decosterd, Susana Alves Saldanha, et al.
Frontiers in Pediatrics|August 14, 2025
Pharmacokinetics of levosimendan in critically Ill children on extracorporeal membrane oxygenation: a prospective observational studyStéphane Bertin, David Haefliger, Maria-Helena Perez, et al.
Pageof 11